Mel Bridges has over 30 years’ experience in the diagnostic and healthcare industries. During this period, Mel has founded and managed successful diagnostics, therapeutics and medical
device businesses, co-founding ASX listed Panbio Limited and ImpediMed Limited. During the past three years, Mel has also served a number of prominent roles as director and chairman of public healthcare companies, including chairman of Alchemia Limited, director of ImpediMed Limited, and director of Campbell Brothers and Benitec Limited. Mel also has deep experience with healthcare/biotechnology companies, having served multiple board posts such as chairman of Peptech Limited and non-executive director of Domantis plc.

Mr. Jones, 46, was appointed to the Board on 19 November 2008.  He also serves as a member of the Company’s Audit Committee and its Corporate Governance Committee and is a former Executive Director and Chief Executive Officer of Aeris Environmental Ltd., Prior to joining Aeris, he was Managing Director of Datex-Ohmeda Australasia (now part of GE Healthcare). He is currently a Director of Fresh Investments Pty Ltd.

Dr. Brandon, 62, was appointed to the Board on 5 October 2009 and also serves on the Company’s Audit Committee.  He has spent his career in the biotech and life sciences sector where he has over 35 years experience in commercially focused research and development and in building successful companies which have commercialised a wide range of Australian and international technologies.  As the founding director of the Centre for Animal Biotechnology, Dr. Brandon was also responsible for fund raising and the development of many important agricultural technologies and products.  He was co-founder and Director of Stem Cell Sciences Ltd. and Smart Drug Systems Inc. and is currently the Managing Director of genetics and artificial animal breeding company Clone International which uses cloning technologies to breed elite cattle, sheep and horses and to preserve the genetics of elite animals.

Mr. Bonvino, 49, was appointed to the Board on 25 November 2009. He has over 27 years experience in consumer marketing and product development and has managed companies for various Italian, Spanish and French firms, distributing and marketing goods throughout South-East Asia. He has established strong bilateral trade relationships between Australian and European companies in the technology and consumer goods sectors. Mr. Bonvino was the former Chief Executive Officer of IM Medical Ltd., an ASX-listed company committed to the use of innovative technology to promote health and well being, spearheading the strategic review which led to significant expansion of the IM Medical business. He also spent time as a Board member of the Italian Chamber of Commerce from 2001 to March 2009, spending the last four years as Vice President.